Viyash Scientific Limited (BOM:512529)
India · Delayed Price · Currency is INR 279.00
-10.40 (-3.59%)
At close: Jul 7, 2026
Viyash Scientific Market Cap
Viyash Scientific has a market cap or net worth of 121.77 billion as of July 7, 2026. Its market cap has increased by 146.18% in one year.
Market Cap
121.77B
Enterprise Value
126.01B
Revenue
34.20B
Ranking
n/a
PE Ratio
69.58
Stock Price
279.00
Market Cap Chart
Since January 5, 2005, Viyash Scientific's market cap has increased from 347.75M to 121.77B, an increase of 34,917.45%. That is a compound annual growth rate of 31.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 121.77B | 34.27% |
| Dec 31, 2025 | 90.70B | 106.22% |
| Dec 31, 2024 | 43.98B | 55.47% |
| Dec 29, 2023 | 28.29B | 29.89% |
| Dec 30, 2022 | 21.78B | -45.17% |
| Dec 31, 2021 | 39.72B | -4.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 383.85B |
| Rubicon Research | 224.42B |
| Granules India | 211.72B |
| AstraZeneca Pharma India | 205.56B |
| Caplin Point Laboratories | 199.54B |
| Jubilant Pharmova | 156.16B |
| CORONA Remedies | 121.64B |
| Procter & Gamble Health | 104.93B |